Table 3 Associations between HCV positivity (anti-HCV antibodies and/or HCV RNA positive) and exposures to potential routes of HCV transmission in a sample of the Egyptian population
From: Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence
Route of Transmission | Exposure Response | Exposure, N | HCV Prevalence, % | Unadjusted OR (95 % CI) | Adjusted OR (95 % CI)a |
|---|---|---|---|---|---|
Received PAT | No | 1408 | 23.1 | Ref. | Ref. |
Yes | 305 | 60.2 | 1.62 (1.22, 2.16) | 1.54 (1.14, 2.11) | |
Blood Transfusion | No | 1417 | 29.1 | Ref. | Ref. |
Yes | 324 | 32.1 | 1.16 (0.87, 1.53) | 1.31 (0.96, 1.79) | |
Blood Donation | No | 1252 | 31.4 | Ref | Ref. |
Yes | 487 | 25.7 | 0.76 (0.59, 0.98) | 0.76 (0.57, 1.02) | |
Diabetes Diagnosis | No | 1251 | 28.5 | Ref. | Ref. |
Yes | 184 | 39.1 | 1.61 (1.16, 2.22) | 1.23 (0.87, 1.76) | |
Number of Injections | Less than 10 injections | 116 | 24.1 | Ref | Ref. |
10 or more injections | 1209 | 30.0 | 1.35 (0.87, 2.10) | 1.24 (0.76, 2.02) | |
Has injections frequently/continuously | 92 | 31.5 | 1.45 (0.78, 2.67) | 1.23, (0.63, 2.41) |